| Year |
Citation |
Score |
| 2015 |
Geyer MB, Radhakrishnan K, Giller R, Umegaki N, Harel S, Kiuru M, Morel KD, LeBoeuf N, Kandel J, Bruckner A, Fabricatore S, Chen M, Woodley D, McGrath J, Baxter-Lowe L, et al. Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa. The Journal of Pediatrics. PMID 26148662 DOI: 10.1016/J.Jpeds.2015.05.051 |
0.311 |
|
| 2012 |
Harel S, Tu EY, Weisberg S, Esquilin M, Chambers SM, Liu B, Carson CT, Studer L, Reizis B, Tomishima MJ. ZFX controls the self-renewal of human embryonic stem cells. Plos One. 7: e42302. PMID 22879936 DOI: 10.1371/Journal.Pone.0042302 |
0.769 |
|
| 2007 |
Galan-Caridad JM, Harel S, Arenzana TL, Hou ZE, Doetsch FK, Mirny LA, Reizis B. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell. 129: 345-57. PMID 17448993 DOI: 10.1016/J.Cell.2007.03.014 |
0.55 |
|
| 2006 |
Reizis B, Harel S, Galan JM, Arenzana TL. Zfx Is an Essential and Specific Regulator of Hematopoietic Stem Cell Self-Renewal. Blood. 108: 863-863. DOI: 10.1182/Blood.V108.11.863.863 |
0.548 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Harel S, Higgins CA, Cerise JE, Dai Z, Chen JC, Clynes R, Christiano AM. Pharmacologic inhibition of JAK-STAT signaling promotes hair growth. Science Advances. 1: e1500973. PMID 26601320 DOI: 10.1126/Sciadv.1500973 |
0.295 |
|
| 2016 |
Wang E, Harel S, Christiano AM. JAK-STAT Signaling Jump Starts the Hair Cycle. The Journal of Investigative Dermatology. 136: 2131-2132. PMID 27772548 DOI: 10.1016/J.Jid.2016.08.029 |
0.271 |
|
| 2017 |
Hyun Ah Kwon A, Wang E, DeStefano G, Patel A, Drill E, Harel S, Cera C, Tavazoie M, Christiano A. 496 Identification of differentially expressed miRNAs in alopecia areata that target immune-regulatory pathways Journal of Investigative Dermatology. 137: S85. DOI: 10.1016/J.Jid.2017.02.516 |
0.209 |
|
| 2024 |
Wipperman MF, Gayvert KM, Atanasio A, Wang CQ, Corren J, Covarrubias A, Setliff I, Chio E, Laws E, Wolfe K, Harel S, Maloney J, Herman G, Orengo JM, Lim WK, et al. Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy. Allergy. PMID 38279910 DOI: 10.1111/all.16001 |
0.205 |
|
| 2014 |
Higgins CA, Petukhova L, Harel S, Ho YY, Drill E, Shapiro L, Wajid M, Christiano AM. FGF5 is a crucial regulator of hair length in humans. Proceedings of the National Academy of Sciences of the United States of America. 111: 10648-53. PMID 24989505 DOI: 10.1073/Pnas.1402862111 |
0.192 |
|
| 2014 |
Xing L, Dai Z, Jabbari A, Cerise JE, Higgins CA, Gong W, de Jong A, Harel S, DeStefano GM, Rothman L, Singh P, Petukhova L, Mackay-Wiggan J, Christiano AM, Clynes R. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nature Medicine. 20: 1043-9. PMID 25129481 DOI: 10.1038/Nm.3645 |
0.169 |
|
| 2012 |
Harel S, Christiano AM. Keratin 71 mutations: from water dogs to woolly hair. The Journal of Investigative Dermatology. 132: 2315-7. PMID 22971920 DOI: 10.1038/Jid.2012.291 |
0.164 |
|
| 2012 |
Harel S, Christiano AM. Genetics of Structural Hair Disorders. The Journal of Investigative Dermatology. 132: E22-6. PMID 26875438 DOI: 10.1038/Skinbio.2012.7 |
0.15 |
|
| 2012 |
Harel S, Christiano AM. Genetics of structural hair disorders. The Journal of Investigative Dermatology. 132: E22-6. PMID 23154628 DOI: 10.1038/skinbio.2012.7 |
0.15 |
|
| 2019 |
Maspero JF, Katelaris CH, Busse WW, Castro M, Corren J, Chipps BE, Peters AT, Pavord ID, Ford LB, Sher L, Rabe KF, Rice MS, Rowe P, Lu Y, Harel S, et al. Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma With Self-reported Chronic Rhinosinusitis. The Journal of Allergy and Clinical Immunology. in Practice. PMID 31351189 DOI: 10.1016/J.Jaip.2019.07.016 |
0.133 |
|
| 2004 |
Davidson TJ, Harel S, Arboleda VA, Prunell GF, Shelanski ML, Greene LA, Troy CM. Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10040-6. PMID 15537872 DOI: 10.1523/Jneurosci.3643-04.2004 |
0.12 |
|
| 2021 |
Kosloski MP, Kalliolias GD, Xu CR, Harel S, Lai CH, Zheng W, Davis JD, Kamal MA. Pharmacokinetics and Pharmacodynamics of Itepekimab in Healthy Adults and Patients With Asthma: Phase I First-in-Human and First-in-Patient Trials. Clinical and Translational Science. PMID 34523807 DOI: 10.1111/cts.13157 |
0.078 |
|
| 2021 |
Hamilton JD, Harel S, Swanson BN, Brian W, Chen Z, Rice MS, Amin N, Ardeleanu M, Radin A, Shumel B, Ruddy M, Patel N, Pirozzi G, Mannent L, Graham NMH. Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases. Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology. PMID 34037993 DOI: 10.1111/cea.13954 |
0.05 |
|
| 2019 |
Corren J, Castro M, O'Riordan T, Hanania NA, Pavord ID, Quirce S, Chipps BE, Wenzel SE, Thangavelu K, Rice MS, Harel S, Jagerschmidt A, Khan A, Kamat S, Maroni J, et al. Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma. The Journal of Allergy and Clinical Immunology. in Practice. PMID 31521831 DOI: 10.1016/J.Jaip.2019.08.050 |
0.026 |
|
| 2021 |
Bachert C, Corren J, Lee SE, Zhang H, Harel S, Cunoosamy D, Khan AH, Jacob-Nara JA, Siddiqui S, Nash S, Rowe PJ, Deniz Y. Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials. International Forum of Allergy & Rhinology. PMID 34970860 DOI: 10.1002/alr.22964 |
0.022 |
|
| 2023 |
Faiz A, Mahbub RM, Boedijono FS, Tomassen MI, Kooistra W, Timens W, Nawijn M, Hansbro PM, Johansen MD, Pouwels SD, Heijink IH, Massip F, de Biase MS, Schwarz RF, Adcock IM, ... ... Harel S, et al. IL-33 Expression Is Lower in Current Smokers at Both Transcriptomic and Protein Level. American Journal of Respiratory and Critical Care Medicine. PMID 37708400 DOI: 10.1164/rccm.202210-1881OC |
0.02 |
|
| 2023 |
Bachert C, Laidlaw TM, Cho SH, Mullol J, Swanson BN, Naimi S, Classe M, Harel S, Jagerschmidt A, Laws E, Ruddy M, Praestgaard A, Amin N, Mannent LP. Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results. The Annals of Otology, Rhinology, and Laryngology. 34894231176334. PMID 37322842 DOI: 10.1177/00034894231176334 |
0.019 |
|
| 2020 |
Busse WW, Maspero JF, Lu Y, Corren J, Hanania NA, Chipps BE, Katelaris CH, FitzGerald JM, Quirce S, Ford LB, Rice MS, Kamat S, Khan AH, Jagerschmidt A, Harel S, et al. Dupilumab improves clinical outcomes in patients with asthma and perennial allergic rhinitis. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. PMID 32474156 DOI: 10.1016/J.Anai.2020.05.026 |
0.015 |
|
| 2021 |
Busse WW, Wenzel SE, Casale TB, FitzGerald JM, Rice MS, Daizadeh N, Deniz Y, Patel N, Harel S, Rowe PJ, Graham NMH, O'Riordan T, Pavord ID. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. The Lancet. Respiratory Medicine. PMID 34181876 DOI: 10.1016/S2213-2600(21)00124-7 |
0.014 |
|
| 2022 |
Pavord ID, Deniz Y, Corren J, Casale TB, FitzGerald JM, Izuhara K, Daizadeh N, Ortiz B, Johnson RR, Harel S, Djandji M, Goga L, Crikelair N, Rowe PJ, Busse WW. Baseline FeNO Independently Predicts the Dupilumab Response in Patients with Moderate-To-Severe Asthma. The Journal of Allergy and Clinical Immunology. in Practice. PMID 36535524 DOI: 10.1016/j.jaip.2022.11.043 |
0.01 |
|
| Hide low-probability matches. |